Biotech & Health
Warhound dog gene editing: $200M to clone explosive-detecting canines
Sequoia Capital and Colossal Biosciences committed the entire $200 million. The resulting puppies are expected to carry the engineered traits from birth.
biotech
4 stories
More in biotech
- Biotech & AI
Enveda Raises $311M Series E to Accelerate Nature-Derived AI Drug Trials
Enveda's $311 million Series E funding fuels AI-powered discovery of plant-based medicines and moves multiple candidates into human trials.
- Technology
AI Bioweapon Risk: CEOs Call for Slowed Progress Amid Biotech Threat
Top AI leaders highlight the AI bioweapon risk and urge a deliberate slowdown, prompting biotech firms and regulators to tighten safeguards.
- Technology
The Download: anti-aging drug claims and virtual power plants
Generation Lab touts a secret drug combo that "rejuvenates blood," but missing data and opaque chemistry raise serious doubts.